These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 10715413)
21. Prolonged graft survival induced by CTLA4IG-gene transfection combined with FTY720 administration in rat heart grafting. Kita Y; Li XK; Funeshima N; Enosawa S; Tamura A; Hayashi S; Suzuki K; Kazui T; Amemiya H; Suzuki S Transplant Proc; 1999 Nov; 31(7):2787-8. PubMed ID: 10578291 [No Abstract] [Full Text] [Related]
22. Novel insights into the mechanism of action of FTY720 in a transgenic model of allograft rejection: implications for therapy of chronic rejection. Habicht A; Clarkson MR; Yang J; Henderson J; Brinkmann V; Fernandes S; Jurewicz M; Yuan X; Sayegh MH J Immunol; 2006 Jan; 176(1):36-42. PubMed ID: 16365393 [TBL] [Abstract][Full Text] [Related]
23. Immunosuppressive effect of a new drug, FTY720, on lymphocyte responses in vitro and cardiac allograft survival in rats. Suzuki S; Enosawa S; Kakefuda T; Li XK; Mitsusada M; Takahara S; Amemiya H Transpl Immunol; 1996 Sep; 4(3):252-5. PubMed ID: 8893458 [No Abstract] [Full Text] [Related]
24. Effect of peritransplant FTY720 alone or in combination with posttransplant FK 506 in a rat model of cardiac allotransplantation. Xu M; Antoniou EA; Afford SC; Suzuki S; Pirenne J; McMaster P; D'Silva M Transplant Proc; 1997 Nov; 29(7):2964-6. PubMed ID: 9365631 [No Abstract] [Full Text] [Related]
25. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767 [TBL] [Abstract][Full Text] [Related]
27. The imbalance between Treg and Th17 cells caused by FTY720 treatment in skin allograft rejection. Commodaro AG; Pedregosa JF; Peron JP; Brandão W; Rizzo LV; Bueno V Clinics (Sao Paulo); 2012 Jul; 67(7):805-13. PubMed ID: 22892927 [TBL] [Abstract][Full Text] [Related]
28. Prevention of graft rejection and graft-versus-host reaction by a novel immunosuppressant, FTY720, in rat small bowel transplantation. Mitsusada M; Suzuki S; Kobayashi E; Enosawa S; Kakefuda T; Miyata M Transpl Int; 1997; 10(5):343-9. PubMed ID: 9287398 [TBL] [Abstract][Full Text] [Related]
29. FTY720: mechanisms of action and its effect on organ transplantation (review). Suzuki S Transplant Proc; 1999 Nov; 31(7):2779-82. PubMed ID: 10578288 [No Abstract] [Full Text] [Related]
30. Perioperative administration of FTY720 and CTLA4IG in rat heart transplantation. Ohba M; Li XK; Kita Y; Tamura A; Enosawa S; Sasakuri S; Ogoshi S; Amemiya H; Suzuki S Transplant Proc; 2000 Nov; 32(7):2024-5. PubMed ID: 11120049 [No Abstract] [Full Text] [Related]
31. Induction of lymphocyte apoptosis in rat liver allograft with ongoing rejection by FTY720. Li XK; Tamura A; Fujino M; Guo L; Kakefuda T; Funeshima N; Enosawa S; Amari M; Naoe S; Amemiya H; Suzuki S Clin Exp Immunol; 2001 Feb; 123(2):331-9. PubMed ID: 11207666 [TBL] [Abstract][Full Text] [Related]
32. Protection of mouse small bowel allografts by FTY720 and costimulation blockade. Yan S; Rodriguez-Barbosa JI; Pabst O; Beckmann JH; Brinkmann V; Förster R; Hoffmann MW Transplantation; 2005 Jun; 79(12):1703-10. PubMed ID: 15973172 [TBL] [Abstract][Full Text] [Related]
33. Prolongation of concordant xenograft survival by a newly developed drug, FTY720. Fujiwara I; Nakajima H; Matsuda T; Mizuta N; Yamagishi H; Oka T Transplant Proc; 1999 Nov; 31(7):2831-3. PubMed ID: 10578306 [No Abstract] [Full Text] [Related]
34. FTY720, a novel immunosuppressant, prolongs rat skin allograft survival by decreasing T-cell infiltration into grafts. Yanagawa Y; Hoshino Y; Kataoka H; Kawaguchi T; Ohtsuki M; Sugahara K; Chiba K Transplant Proc; 1999; 31(1-2):1227-9. PubMed ID: 10083548 [No Abstract] [Full Text] [Related]
35. Rescue therapy with rapamycin blocks an ongoing process of heart allograft rejection. Ferraresso M; Wang ME; Stepkowski SM; Kahan BD Transplant Proc; 1993 Feb; 25(1 Pt 1):729. PubMed ID: 8438460 [No Abstract] [Full Text] [Related]
36. FTY720, a new immunosuppressant, as rescue therapy in mouse cardiac transplantation. Wang MH; Milekhin V; Zhang H; Huang HZ Acta Pharmacol Sin; 2003 Sep; 24(9):847-52. PubMed ID: 12956930 [TBL] [Abstract][Full Text] [Related]
37. Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat. Chen H; Wu J; Xu D; Luo H; Daloze P Transplant Proc; 1993 Feb; 25(1 Pt 1):719-20. PubMed ID: 8438454 [No Abstract] [Full Text] [Related]
38. Effect of a novel immunosuppressant, FTY720, on allograft survival after renal transplant in rats. Ueda H; Takahara S; Azuma H; Kusaka M; Suzuki S; Katsuoka Y Eur Surg Res; 2000; 32(5):279-83. PubMed ID: 11111172 [TBL] [Abstract][Full Text] [Related]
39. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD. Nikolova Z; Hof A; Baumlin Y; Hof RP Transpl Immunol; 2000 Jun; 8(2):115-24. PubMed ID: 11005317 [TBL] [Abstract][Full Text] [Related]
40. Effect of FTY720 and ex vivo graft irradiation in rat small bowel transplantation: apoptosis of crypt cells and lymphocytes. Sugito K; Inoue M; Ikeda T; Hagiwara N; Koshinaga T; Kusafuka T Transplant Proc; 2007 Dec; 39(10):3432-5. PubMed ID: 18089399 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]